Lupin has onboarded Dr. Fabrice Egros as President, Corporate Development and Growth Markets. Dr. Egros takes over the Corporate Development role from Alan Butcher departing from the Company on
28 February 2022. Dr. Egros will lead the development and execution of the Company's inorganic growth strategy, including mergers and acquisitions, business development, in-licensing arrangements,
and related matters. He will continue to lead business in LATAM and Asia regions in this new role.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
